NCT06476483

Brief Summary

This study aims to understand if implementing DIALOG+ in an inpatient psychiatric rehabilitation setting is feasible (can the intervention be implemented) and acceptable (how the intervention is perceived by staff and patient participants). If the intervention is proven to be feasible and acceptable a larger-scale study may take place. This study has been developed in response to the trust-wide implementation of DIALOG outcome measures. DIALOG+ offers additional solution-focused and person-centred follow-up questions to the DIALOG questions and links to multidisciplinary team (MDT) discussions. It is hoped that the conversations had during DIALOG+ meetings will support positive outcomes, and the learning gathered from this study will drive change and improvement for other people requiring psychiatric rehabilitation inpatient admissions in the future. DIALOG+ has been successfully implemented in community settings in the national health service (NHS) but has not been implemented in psychiatric rehabilitation inpatient settings. This study will aim to recruit patient and staff participants from NHS psychiatric rehabilitation inpatient wards. Patient participants who will be eligible to take part are those who can consent, are between the ages of 18-65, and can complete DIALOG and DIALOG+. To understand the feasibility of the intervention, descriptive statistics will be collected and to understand acceptability focus groups will take place and surveys will be collected. Quantitative data collection will take place over 5 months and will be split into 2 groups. Group one will be a comparison group where participants will act as an extended baseline group and biweekly DIALOG outcomes will be collected. Group 2 will be a Treatment group and participants will receive the DIALOG+ intervention intervention, DIALOG outcomes will be collected biweekly as part of the intervention. Finally, there will be a period to gather qualitative feedback from patient participants using surveys, and from staff participants using focus groups or semi-structured interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 26, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

October 9, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
24 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2025

Completed
Last Updated

March 13, 2026

Status Verified

May 1, 2024

Enrollment Period

7 months

First QC Date

May 20, 2024

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (12)

  • Feasibility outcome- Recruitment rate/consent rate

    The number of people who agreed and consented to participate in the study out of the total number of eligible participants approached. Reported as a percentage.

    assessed at the end of the study (after 5 months)

  • Feasibility outcome- Number of eligible participants.

    Eligible participants are those who meet the inclusion criteria, reported as a count of participants.

    assessed at the end of the study (after 5 months)

  • Feasibility outcome- Participation rate

    The proportion of those who consented and agreed to engage in DIALOG and DIALOG+ out of the number of participants who engaged in the intervention after consenting. Reported as a percentage of participants.

    assessed at the end of the study (after 5 months)

  • Feasibility outcome- Completion rate

    The proportion of those who completed the intervention out of the number who consented and engaged in DIALOG and DIALOG+. Reported as a percentage of participants.

    assessed at the end of the study (after 5 months)

  • Feasibility outcome- Drop out rate

    The number of participants who completed the intervention out of total number of patients enrolled. Reported as a percentage of participants.

    assessed at the end of the study (after 5 months)

  • Feasibility outcomes- Reasons for drop out

    Reasons for drop out will be assessed when by asking the participant after drop out.

    assessed at the end of the study (after 5 months)

  • Feasibility outcomes- Follow up rate

    The number of patients willing to engage in follow-up surveys related to the study out of the total number of participants enrolled in the study. Reported as a percentage of participants.

    assessed at the end of the study (after 5 months)

  • Feasibility outcome- The willingness of clinicians to recruit participants

    Number of staff members who attend DIALOG+ training and implement intervention out of the total number of staff offered to participate. Reported as a percentage.

    assessed at the end of the study (after 5 months)

  • Feasibility outcome- Average number of DIALOG+ sessions

    Reported as the average number of participants.

    assessed at the end of the study (5 months)

  • Acceptability outcome- Cost

    Analysing the cost and benefits of implementing the intervention (including staff training). Reported as a total amount or duration of time spent on training (minutes).

    assessed at the end of the study (after 5 months)

  • Number of staff participants who find DIALOG and DIALOG+ feasible and acceptable to implement in an inpatient rehabilitation setting. Assessed using thematic analysis of focus groups.

    To assess the acceptability of the intervention a theoretical framework (Sekhon et al., 2017) was used. Feasibility objectives are defined by Bugge et al., 2013. Focus group transcripts will be subject to a qualitative thematic analysis. Analysis of focus groups will involve coding, organising coding into themes, reviewing themes, and generating a final thematic overview with in relation to the research question (Braun \& Clarke, 2006).

    assessed at the end of the study (after 5 months)

  • Number of patients who find it feasible and acceptable to implement DIALOG and DIALOG+ in an inpatient rehabilitation setting. Assessed using thematic analysis and average scores of patient surveys.

    The questionnaires will be a mixture of open ended questions and Likert Scale questions based on questions asked by Matanov et al. (2021), 8 of the questions are scored on a Likert scale (1-5). The survey will be given to patients post-intervention. Questions on the scale have been specifically developed to assess feasibility and acceptability of DIALOG+. An average total score will be used in the analysis of Likert scale questions. Open-ended questionnaire responses will be subject to a qualitative thematic analysis. Analysis will involve coding, organising coding into themes, reviewing themes, and generating a final thematic overview in relation to the research question (Braun \& Clarke, 2006).

    assessed at the end of the study (after 5 months)

Secondary Outcomes (3)

  • DIALOG questionnaire

    At the beginning of the study, then biweekly for a duration of 5 months with the final measure taken after 5 months

  • Demographic information

    assessed at the end of the study (5 months)

  • Length of admission in months

    assessed at the end of the study (5 months)

Study Arms (2)

DIALOG

OTHER

This is the comparison group, they will complete the DIALOG measure biweekly for 5 months. DIALOG scores pre and post-intervention will be used in the analyses.

Behavioral: DIALOG

DIALOG+

ACTIVE COMPARATOR

This is the treatment group. The participants in this group have agreed to participate in DIALOG+ and will receive the intervention biweekly for 10 sessions (5 months). Pre and post-intervention DIALOG scores will be used in the analysis.

Behavioral: DIALOG+

Interventions

DIALOGBEHAVIORAL

An outcome measure consisting of 11 questions, with 8 related to quality of life and 3 items on treatment satisfaction. Patients can rate their satisfaction on a 7-point scale for each of the 8 life domains and 3 treatment aspects, resulting in scores for both quality of life and treatment satisfaction. The DIALOG scale does not provide any guidance for patient and clinician interactions.

DIALOG

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18-65
  • Capacity to give informed consent as determined by the MDT and through following informed consent processes.
  • Admitted into the inpatient ward
  • Can complete DIALOG and DIALOG+

You may not qualify if:

  • No capacity to consent
  • Insufficient command of the English language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Forest Close

Sheffield, South Yorkshire, s35 0jw, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Feasibility and acceptability study. A mixed methods design will be used to meet the aims of this study. The study will consist of two parts, firstly quantitative; quasi-experimental group comparison design and secondly a qualitative design with data collection based on focus groups and additional surveys being distributed to patients who participate. The independent variable will be membership of the comparison (DIALOG) or treatment (DIALOG+) group. The dependent variable will be scores on the DIALOG measure at the end of the intervention period.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2024

First Posted

June 26, 2024

Study Start

October 9, 2024

Primary Completion

April 30, 2025

Study Completion

May 24, 2025

Last Updated

March 13, 2026

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Data may be made openly available through the data repository at the University of Sheffield depending on the data sharing agreement with the Sheffield health and social care (SHSC).

Locations